Microchips Biotech Incorporated

CMS put $2.8B at risk in 2014, Teva partners with Microchips Biotech (Morning Read)

CMS failed to track subsidies paid to insurers under the PPACA putting $2.8 billion at risk for four months in 2014, Teva partnered with Microchips Biotech.